Lentivirus dissolution buffer solution and application thereof

A lentivirus and buffer technology, applied in the field of lentivirus dissolution buffer, can solve the problems of poor use effect and inability to provide a dissolution environment for lentivirus, and achieve the goals of reducing usage, preventing protein or virus aggregation, and improving transduction efficiency Effect

Pending Publication Date: 2022-01-28
PORTON BIOLOGICS LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of the present invention is to provide a lentivirus lysis solution that can solve the aforementioned problems in view of the poor effect of the existing lentivirus dissolution buffer described in the background technology and the inability to provide a more suitable dissolution environment for the lentivirus. buffer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lentivirus dissolution buffer solution and application thereof
  • Lentivirus dissolution buffer solution and application thereof
  • Lentivirus dissolution buffer solution and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] A lentivirus lysis buffer comprising 3mM Tris, 5% lactose, 35mM proline, 5mM MgCl 2 and 0.005% Tween80, the rest is water, the pH of the lentivirus lysis buffer is 7, and the formula is named TLTM buffer.

[0033] Tris in the formulation of this example is a buffer salt, which is widely used in the field of biomedicine and can be used to maintain the stability of pH. Lactose is a pharmaceutical excipient, which has the effect of maintaining the integrity of the virus and is a protective agent. Proline can stabilize virus structure and enhance virus activity. MgCl 2 It is a pharmaceutical excipient, which can maintain the activity of protein or virus. Tween80, also known as polysorbate 80, is a pharmaceutical excipient that prevents protein or virus aggregation.

Embodiment 2

[0035] A lentivirus lysis buffer comprising 10mM Tris, 20% lactose, 15mM proline, 1mM MgCl 2 , 0.02% Tween80 and 0.05% Poloxamer 188, the rest is water, the pH of the lentivirus lysis buffer is 8, and the formula is named TLTM1 buffer.

Embodiment 3

[0037] A lentivirus lysis buffer comprising 5mM Tris, 10% lactose, 25mM proline, 2mM MgCl 2 , 0.01% Tween80 and 0.1% P407, the rest is water, the pH of the lentivirus lysis buffer is 7.5, and the formula is named TLTM7 buffer.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a lentivirus dissolution buffer solution and application thereof. The lentivirus dissolution buffer solution comprises 3-10 mM of Tris, 15-35 mM of proline, 1-5 mM of MgCl2, 5-20% of lactose, 0.005-0.02% of Tween 80 and the balance of water, the percentage is mass percent, and the pH value of the lentivirus dissolution buffer solution is 7-9. The components of the lentivirus dissolution buffer solution are all pharmaceutic adjuvants, the influence on the lentivirus activity can be avoided, and the virus structure can be stabilized and the virus activity can be enhanced by adding proline into the lentivirus dissolution buffer solution; the Tween80 can be used for preventing protein or virus aggregation; and MgCl2 has the effect of maintaining protein or virus activity, through the combined effect of several components in the formula, the activity and recovery rate of lentivirus during purification can be comprehensively improved, and the transduction efficiency of lentivirus and the positive rate of transduction CAR can be improved.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular to a lentivirus dissolution buffer and application thereof. Background technique [0002] Lentivirus is commonly used in Chimeric Antigen Receptor T-Cell Immunotherapy (CAR-T), which has the advantages of high transduction efficiency, integration of T cell genome and continuous expression of target proteins. Nowadays, CAR-T production is mostly based on lentiviral vector-mediated CAR gene transfer. However, lentivirus is an extremely fragile viral vector, which is greatly affected by shear force, extrusion, temperature, pH, ionic strength, and handling time during the production process; in addition, lentivirus is relatively easy to Aggregation, which poses a great challenge to lentivirus production and storage. [0003] In the prior art, the buffer usually used for lentivirus dissolution is PBS buffer, 50 mM Tris buffer, PBS+4% lactose buffer, DMEM+2%HSA buffer, HATM buffer or HSTM b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N7/02C12N15/867C12N5/10C12R1/93
CPCC12N7/00C12N15/86C12N5/0636C12N2740/15051C12N2740/15043C12N2800/107C12N2510/00C12N2501/2302
Inventor 胡迪超皮川真隋礼丽孔令洁
Owner PORTON BIOLOGICS LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products